Hopp til innhold

Selected items added to basket

Go to basket

News

Showing  1044  hits

Sort by:
|
Narrow search
  1. Immunoglobulin for chronic fatigue syndrome (CFS/ME): systematic reference list

    This is a literature search followed by sorting of relevant research on the effect of immunoglobulin for chronic fatigue syndrome (CFS/ME).

    Forskningskartlegging

    Published

  2. EXOGEN™ in the treatment of non-union fractures

    The present report provides a single technology assessment of EXOGEN™ for the treatment of non-union fractures.

    Health technology assessment

    Published

  3. Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA

    The objective for the present report, is to systematically summarize published results on effectiveness using nitrous oxide in a paediatric setting for small, but painful hospital procedures.

    Health technology assessment

    Published

  4. Our team

    To achieve the objectives of CO-CREATE we have on board a solid team of partner institutions, personnel and advisers, all with leading expertise within their respective fields.

    Article

    Published

  5. Age estimation by ossification stages of the medial clavicular epiphysis: a systematic review

    This systematic review summarizes the evidence on the distribution of chronological age from pre-defined stages of clavicular ossification studied by MRI or CT in living individuals.

    Systematic review

    Published

  6. Stoltenberg and Ottersen members in new Lancet Commission

    Two directors from the Norwegian Institute of Public Health are members of a new commission on synergies between universal health coverage, health security and health promotion.

    News

    Published

  7. Long-term antipsychotic treatment of persons with schizophrenia spectrum disorders: a systematic review

    The objective for this systematic review is to summarize the effects and adverse effects of treatment for two years or longer with antipsychotics in patients with schizophrenia spectrum disorders.

    Systematic review

    Published

  8. Decrease in new type 2 diabetes cases in Norway

    There are fewer new patients with type 2 diabetes. The number of newly diagnosed cases declined from more than 16 000 in 2009 to 11 000 in 2014.

    Research findings

    Published

  9. Development stages of the knee and ankle by CT and MR imaging for estimation of chronological age

  10. Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment

    AHSCT is suggested for rapid and severe development of diffuse systemic sclerosis. We have summarized the effect and safety, conducted a cost analysis and discussed ethics related to the treatment.

    Health technology assessment

    Published

  11. Adults need booster vaccines every ten years

    Not all the vaccines we are given as children give lifelong protection. Some of the vaccines need booster doses in adulthood to maintain protection against disease.

    Article

    Published

  12. When will your child be offered vaccines?

    Here is an overview of when your child will be offered vaccines as part of the Childhood Immunisation Programme.

    Article

    Published

  13. Why is vaccination so important?

    A vaccine activates our immune system without making us sick. Many dangerous infectious diseases can be prevented in this simple and effective way.

    Article

    Published

  14. Before and after vaccination

    Before the vaccination, the public health nurse will ask whether the child is healthy and if there were any reactions after previous vaccines. Most children show little or no reactions to vaccines.

    Article

    Published

  15. Vaccine against tuberculosis (BCG)

    Children in defined risk groups are offered the vaccine in infancy.

    Article

    Published

  16. Vaccine against diphtheria, tetanus, pertussis and poliomyelitis

    Children in 2nd grade (about 7 years) and 10th grade (about 15 years) are offered the vaccine for diphtheria, tetanus, pertussis and poliomyelitis.

    Article

    Published

  17. Vaccine against measles, mumps and rubella (MMR vaccine)

    Children are offered the MMR vaccine against measles, mumps and rubella at the age of 15 months and in 6th grade (approximately 11 years).

    Article

    Published

  18. Vaccine against pneumococcal disease

    Children are offered a vaccine against pneumococcal disease at their 3-, 5- and 12-month check-ups at the public health centre.

    Article

    Published

  19. Vaccine against HPV (human papilloma virus)

    The HPV vaccine has been offered to girls in 7th grade since the 2009/2010 school year. From autumn 2018, boys will also be offered the vaccine.

    Article

    Published

  20. Vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Hib-infection and hepatitis B

    At 3, 5 and 12 months, children are offered a vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Hib infection and hepatitis B at the public health clinic.

    Article

    Published